Analysis of 24-Hour IOP-related Pattern Changes After Medical Therapy.
作者信息
Mansouri Kaweh, Medeiros Felipe A, Liu John H K, De Moraes Carlos G, Weinreb Robert N
机构信息
*Glaucoma Sector, Department of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland †Hamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, CA ‡Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York, NY.
出版信息
J Glaucoma. 2015 Jun-Jul;24(5):396. doi: 10.1097/IJG.0000000000000245.
Abstract
摘要
相似文献
1
Analysis of 24-Hour IOP-related Pattern Changes After Medical Therapy.
J Glaucoma. 2015 Jun-Jul;24(5):396. doi: 10.1097/IJG.0000000000000245.
2
Analysis of 24-Hour IOP-related Pattern Changes After Medical Therapy.
J Glaucoma. 2015 Jun-Jul;24(5):397-8. doi: 10.1097/IJG.0000000000000246.
3
Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension.
Chin Med J (Engl). 2010 Jun;123(11):1417-21.
4
Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma.
J Glaucoma. 2014 Jan;23(1):e6-12. doi: 10.1097/IJG.0b013e31829e5635.
5
Modern alchemy: fixed combinations of glaucoma drugs.
Am J Ophthalmol. 2005 Jul;140(1):125-6. doi: 10.1016/j.ajo.2005.03.034.
6
Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.
BMC Ophthalmol. 2014 Feb 25;14:21. doi: 10.1186/1471-2415-14-21.
7
Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
Am J Ophthalmol. 2003 Aug;136(2):392; author reply 392-3. doi: 10.1016/s0002-9394(03)00247-2.
8
9
Latanoprost versus bimatoprost.
Ophthalmology. 2003 Sep;110(9):1861-2; author reply 1862. doi: 10.1016/S0161-6420(03)00849-2.
10
Comment on Efficacy and tolerability of prostaglandin analogs.
J Glaucoma. 2009 Aug;18(6):498; author reply 498-9. doi: 10.1097/IJG.0b013e3181a98bed.
引用本文的文献
1
Nocturnal Variability of Intraocular Pressure Monitored With Contact Lens Sensor Is Associated With Visual Field Loss in Glaucoma.
J Glaucoma. 2021 Mar 1;30(3):e56-e60. doi: 10.1097/IJG.0000000000001727.
2
Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.
Clin Exp Ophthalmol. 2015 Dec;43(9):787-95. doi: 10.1111/ceo.12567. Epub 2015 Aug 16.
本文引用的文献
1
Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma.
J Glaucoma. 2014 Jan;23(1):e6-12. doi: 10.1097/IJG.0b013e31829e5635.
2
Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and reproducibility in patients with glaucoma.
Arch Ophthalmol. 2012 Dec;130(12):1534-9. doi: 10.1001/jamaophthalmol.2013.1350.
3
Analysis of continuous 24-hour intraocular pressure patterns in glaucoma.
Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8050-6. doi: 10.1167/iovs.12-10569.
4
Effect of head and body position on intraocular pressure.
Ophthalmology. 2012 May;119(5):987-91. doi: 10.1016/j.ophtha.2011.11.024. Epub 2012 Feb 17.
5
Effects of aging on 24-hour intraocular pressure measurements in sitting and supine body positions.
Invest Ophthalmol Vis Sci. 2012 Jan 10;53(1):112-6. doi: 10.1167/iovs.11-8763.
6
Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
Am J Ophthalmol. 2004 Sep;138(3):389-95. doi: 10.1016/j.ajo.2004.04.022.
7
Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes.
Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1586-90. doi: 10.1167/iovs.02-0666.
Zotero 插件